🇺🇸 FDA
Pipeline program

mouse nerve growth factor

2019-KY-026-02

Approved small_molecule active

Quick answer

mouse nerve growth factor for Cerebral Small Vessel Diseases is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Cerebral Small Vessel Diseases
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials